Changzhen Shang

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Long Noncoding Rna

Machine Learning

Metastatic Colorectal Cancer

Top Venues

Cell death & disease

Journal of hepatocellular carcinoma

Journal for immunotherapy of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Yonglin Hua, Zhixian Sun, Yuxin Xiao, Huilong Li, Xiaowu Ma, Xuan Luo, Wenliang Tan, Zhiqin Xie, Ziyu Zhang, Chenwei Tang, Hongkai Zhuang, Weikai Xu, Haihong Zhu, Yajin Chen, Changzhen Shang
Pretreatment CT-based machine learning radiomics model predicts response in unresectable hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors and interventional therapy. Journal for immunotherapy of cancer 12 (7) (2024)
Chenwei Tang, Hongkai Zhuang, Wentao Wang, Qingbin Wang, Xiaowu Ma, Bingkun Wang, Ziyu Zhang, Jiahao Jiang, Zhiqin Xie, Wenliang Tan, Lei Yang, Songyao Liu, Yonglin Hua, Yuxin Xiao, Baoshan Ding, Yajin Chen, Changzhen Shang
CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing BIRC3 mRNA. Cell death & disease 15 (3) (2024)
Chenwei Tang, Hongkai Zhuang, Wentao Wang, Qingbin Wang, Xiaowu Ma, Bingkun Wang, Ziyu Zhang, Jiahao Jiang, Zhiqin Xie, Wenliang Tan, Lei Yang, Songyao Liu, Yonglin Hua, Yuxin Xiao, Baoshan Ding, Yajin Chen, Changzhen Shang
CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing BIRC3 mRNA. Cell death & disease 15 (3) (2024)
Chenwei Tang, Hongkai Zhuang, Wentao Wang, Qingbin Wang, Xiaowu Ma, Bingkun Wang, Ziyu Zhang, Jiahao Jiang, Zhiqin Xie, Wenliang Tan, Lei Yang, Songyao Liu, Yonglin Hua, Yuxin Xiao, Baoshan Ding, Yajin Chen, Changzhen Shang
CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing BIRC3 mRNA. Cell death & disease 15 (3) (2024)
Yajin Chen, Cheng-You Du, Shun-Li Shen, Wu Zhang, Yunfeng Shan, Ang Lyu, Jianhui Wu, Changzhen Shang, Xuan Luo, Jinxing Wei, Heng Xiao, Jian-Guo Qiu, Yunpeng Hua, Shutong Wang, Ting Wang, Shengjie Dai, Shuhao Zhang, Bingying Xie, Yinghao Wu, Chun-Yi Hao
Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Yajin Chen, Cheng-You Du, Shun-Li Shen, Wu Zhang, Yunfeng Shan, Ang Lyu, Jianhui Wu, Changzhen Shang, Xuan Luo, Jinxing Wei, Heng Xiao, Jian-Guo Qiu, Yunpeng Hua, Shutong Wang, Ting Wang, Shengjie Dai, Shuhao Zhang, Bingying Xie, Yinghao Wu, Chun-Yi Hao
Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Yonglin Hua, Zhixian Sun, Yuxin Xiao, Huilong Li, Xiaowu Ma, Xuan Luo, Wenliang Tan, Zhiqin Xie, Ziyu Zhang, Chenwei Tang, Hongkai Zhuang, Weikai Xu, Haihong Zhu, Yajin Chen, Changzhen Shang
Pretreatment CT-based machine learning radiomics model predicts response in unresectable hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors and interventional therapy. Journal for immunotherapy of cancer 12 (7) (2024)
Chenwei Tang, Hongkai Zhuang, Wentao Wang, Qingbin Wang, Xiaowu Ma, Bingkun Wang, Ziyu Zhang, Jiahao Jiang, Zhiqin Xie, Wenliang Tan, Lei Yang, Songyao Liu, Yonglin Hua, Yuxin Xiao, Baoshan Ding, Yajin Chen, Changzhen Shang
CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing BIRC3 mRNA. Cell death & disease 15 (3) (2024)
Yonglin Hua, Zhixian Sun, Yuxin Xiao, Huilong Li, Xiaowu Ma, Xuan Luo, Wenliang Tan, Zhiqin Xie, Ziyu Zhang, Chenwei Tang, Hongkai Zhuang, Weikai Xu, Haihong Zhu, Yajin Chen, Changzhen Shang
Pretreatment CT-based machine learning radiomics model predicts response in unresectable hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors and interventional therapy. Journal for immunotherapy of cancer 12 (7) (2024)
Qingbin Wang, Bingkun Wang, Xiaowu Ma, Hongkai Zhuang, Zhiqin Xie, Chenwei Tang, Wenliang Tan, Lei Yang, Changzhen Shang, Yajin Chen
Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 10 (2023)
Qingbin Wang, Bingkun Wang, Xiaowu Ma, Hongkai Zhuang, Zhiqin Xie, Chenwei Tang, Wenliang Tan, Lei Yang, Changzhen Shang, Yajin Chen
Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 10 (2023)
Xiaowu Ma, Hongkai Zhuang, Qingbin Wang, Lei Yang, Zhiqin Xie, Ziyu Zhang, Wenliang Tan, Chenwei Tang, Yajin Chen, Changzhen Shang
SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression. Journal of hepatocellular carcinoma 9 (2022)
Lei Yang, Wenliang Tan, Yingcheng Wei, Zhiqin Xie, Wenxin Li, Xiaowu Ma, Qingbin Wang, Huilong Li, Ziyu Zhang, Changzhen Shang, Yajin Chen
CircLIFR suppresses hepatocellular carcinoma progression by sponging miR-624-5p and inactivating the GSK-3β/β-catenin signaling pathway. Cell death & disease 13 (5) (2022)
Sicong Zhu, Xuelian Huang, Kelin Zhang, Wenliang Tan, Zhirong Lin, Qing He, Yajin Chen, Changzhen Shang
Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma. Cancer medicine 8 (18) (2019)